混合冷沉淀凝血因子质量标准探索

李小春 ,  刘星辰

中国输血杂志 ›› 2026, Vol. 39 ›› Issue (8) : 1125 -1129.

PDF (1236KB)
中国输血杂志 ›› 2026, Vol. 39 ›› Issue (8) : 1125 -1129. DOI: 10.13303/j.cjbt.issn.1004-549x.2026.08.019
论著

混合冷沉淀凝血因子质量标准探索

作者信息 +

Exploration of quality standards for pooled cryoprecipitate coagulation factors

Author information +
文章历史 +
PDF (1265K)

摘要

目的 建立基于实测数据的混合冷沉淀凝血因子质量标准,解决单袋冷沉淀因个体差异导致的凝血因子含量波动大、临床剂量不精准的问题。方法 纳入 120 袋不同血型新鲜冰冻血浆,分别采用离心法和虹吸法制备单袋冷沉淀,每 5 袋同血型、同方法冷沉淀汇集为一袋混合冷沉淀。 测定原料血浆、单袋冷沉淀及混合冷沉淀的Ⅷ因子含量、纤维蛋白原含量及容量,计算回收率与变异系数,分析混合工艺对产品质量均一性的影响。结果 混合冷沉淀的Ⅷ因子含量、纤维蛋白原含量及容量均显著高于单袋冷沉淀。 混合后Ⅷ因子含量的变异系数由单袋的34. 9% ~35. 2%降至 18. 2% ~20. 7%,纤维蛋白原含量的变异系数由 27. 0% ~28. 6%降至 13. 1% ~13. 4%。 混合操作对Ⅷ因子及纤维蛋白原回收率无显著影响(P>0. 05)。结论 基于 5 袋汇集制备混合冷沉淀,建议质量标准为:Ⅷ因子含量≥400 IU/ 袋、纤维蛋白原含量≥750 mg/ 袋、容量 200~250 mL/ 袋,无菌试验合格。 该标准可为混合冷沉淀的规模化制备与临床应用提供依据。

Abstract

Objective To establish quality standards for pooled cryoprecipitate based on measured data, addressing the issues of wide variability in coagulation factor content attributable to individual donor differences and imprecise clinical dosing with single-bag cryoprecipitate. Methods A total of 120 bags of fresh frozen plasma of different ABO blood groups were enrolled. Single-bag cryoprecipitate was prepared using either the centrifugation method or the siphonage method. For each blood group and each preparation method, every five single units of the same blood group were pooled into one bag of pooled cryoprecipitate. Factor Ⅷ content, fibrinogen content, and volume were measured in source plasma, single-bag cryoprecipitate, and pooled cryoprecipitate. Recovery rates and coefficients of variation were calculated, and the effect of the pooling process on product homogeneity was analyzed. Results The factor Ⅷ content, fibrinogen content, and volume of pooled cryoprecipitate were significantly higher than those of single-unit cryoprecipitate and were linearly correlated with the number of units pooled. After pooling, the coefficient of variation for factor Ⅷ content decreased from 34. 9%-35. 2% (single units) to 18. 2%-20. 7% (pools), and the coefficient of variation for fibrinogen content decreased from 27. 0%-28. 6% to 13. 1%-13. 4%. The pooling procedure had no significant effect on the recovery rates of factor Ⅷ or fibrinogen (P>0. 05). Conclusion For pooled cryoprecipitate prepared by pooling five single units, the proposed quality standards are: factor Ⅷ content ≥400 IU/ bag, fibrinogen content ≥ 750 mg/ bag, volume 200-250 mL/ bag, and sterility test negative. These standards can provide a basis for large-scale preparation and clinical application of pooled cryoprecipitate.

关键词

混合冷沉淀 / Ⅷ因子 / 纤维蛋白原 / 质量标准 / 汇集制备

Key words

pooled cryoprecipitate / factor Ⅷ / fibrinogen / quality standards / pooled preparation

引用本文

引用格式 ▾
李小春,刘星辰. 混合冷沉淀凝血因子质量标准探索[J]. 中国输血杂志, 2026, 39(8): 1125-1129 DOI:10.13303/j.cjbt.issn.1004-549x.2026.08.019

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

CALLUM J L, KARKOUTI K, LIN Y. Cryoprecipitate: The Current State of Knowledge[J].Transfusion Medicine Reviews, 2009, 23(3):177-188.

[2]

British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant[J].British Journal of Haematology, 2004, 126(1):11-28.

[3]

EVANS B A, KAMYSZEK R W, PIEGORE M, et al. Global sources of cryoprecipitate demonstrate variability in coagulant factor levels and functional hemostasis[J].Blood Coagulation & Fibrinolysis, 2021, 32(2):87-102.

[4]

AABB. Standards for blood banks and transfusion services[M]. Bethesda, Maryland:AABB,2018.

[5]

NASCIMENTO B, GOODNOUGH L T, LEVY J H. Cryoprecipitate therapy[J].British Journal of Anaesthesia, 2014, 113(6):922-934.

[6]

全血及成分血质量要求[S]. GB 18469-2012.

[7]

Quality requirements for whole blood and blood components[S]. GB 18469-2012.

[8]

SHEFFIELD W P, BHAKTA V, JENKINS C. Stability of coagulation protein activities in single units or pools of cryoprecipitate during storage at 20-24℃ for up to 24 h[J].Vox Sanguinis, 2016, 110(1):12-19.

[9]

LOKHANDWALA P M, O’ NEAL A, PATEL E U, et al. Hemostatic profile and safety of pooled cryoprecipitate up to 120 hours after thawing[J].Transfusion, 2018, 58(5):1126-1131.

[10]

VIPIN V, GEEVAR T, SAMUEL M A, et al. Hemostatic profile and safety of pooled cryoprecipitate on extended storage after thawing[J].Asian Journal of Transfusion Science, 2026.

[11]

GREEN L, BOLTON-MAGGS P, BEATTIE C, et al. British Society of Haematology Guidelines on the spectrum of fresh frozen plasma and cryoprecipitate products: their handling and use in various patient groups in the absence of major bleeding[J].British Journal of Haematology, 2018, 181(1):54-67.

基金资助

成都市血液中心课题(202201)

AI Summary AI Mindmap
PDF (1236KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉